Related Experiment Video

Updated: Oct 16, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.5K

The Role of microRNA in Pancreatic Cancer

Beata Smolarz1, Adam Durczyński2, Hanna Romanowicz1

  • 1Laboratory of Cancer Genetics, Department of Pathology, Polish Mother's Memorial Hospital Research Institute, 93-338 Lodz, Poland.

Biomedicines
|October 23, 2021
PubMed

Insights

MicroRNAs (miRNAs) are crucial for gene regulation and show promise in cancer therapy. In pancreatic cancer, circulating miRNAs can indicate disease progression and aggressiveness, highlighting their diagnostic potential.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression post-transcriptionally.
  • Dysregulation of miRNA expression is implicated in various human diseases, including cancer.
  • Pancreatic cancer remains a highly lethal malignancy with limited effective therapeutic options.

Purpose of the Study:

  • To review the current literature on the role of microRNAs in pancreatic cancer development.
  • To explore the potential of circulating miRNAs as biomarkers for pancreatic cancer progression and aggressiveness.
  • To highlight the therapeutic implications of targeting miRNAs in pancreatic cancer.

Main Methods:

  • Literature review of recent studies on microRNAs and pancreatic cancer.
  • Analysis of research focusing on miRNA expression profiles in pancreatic tumors and bodily fluids.
  • Evaluation of studies investigating the functional roles of specific miRNAs in pancreatic carcinogenesis.

Main Results:

  • MicroRNA dysregulation is a common feature in pancreatic cancer.
  • Specific circulating miRNAs show altered expression patterns correlating with tumor stage and patient outcomes.
  • MicroRNAs influence multiple pathways involved in pancreatic cancer initiation and progression.

Conclusions:

  • MicroRNAs are significantly involved in the pathogenesis of pancreatic cancer.
  • Circulating miRNAs hold promise as non-invasive biomarkers for early detection and monitoring of pancreatic cancer.
  • Targeting microRNA pathways represents a potential novel therapeutic strategy for pancreatic cancer.
Keywords:
miRNApancreatic cancertherapeutic potential

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.0K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.5K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K